Evidence map›Paper›PMID 40968016›Full record

ArticleAJNR. American journal of neuroradiology2025

Hybrid [

Faizullah Mashriqi, Michelle Chen, Graham Keir, Chris Caravella, Anuj Goenka, Sean A P Clouston, Josephine Rini, Ana M Franceschi

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in AJNR. American journal of neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Faizullah MashriqiFrom the Neuroradiology Division (F.M., M.C., A.M.F.), Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, New York.ORCID https://orcid.org/0000-0002-8043-5973
Michelle ChenFrom the Neuroradiology Division (F.M., M.C., A.M.F.), Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, New York.
Graham KeirPiedmont South Imaging (G.K.), Atlanta, Georgia.ORCID https://orcid.org/0000-0001-7597-8378
Chris CaravellaDivision of Nuclear Medicine (C.C., J.R.), Department of Radiology, New York University School of Medicine, New York, New York.ORCID https://orcid.org/0000-0001-7156-2658
Anuj GoenkaDepartment of Radiation Oncology (A.G.), Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York.ORCID https://orcid.org/0000-0002-1946-2307
Sean A P CloustonDepartment of Family, Population and Preventive Medicine (S.A.P.C.), Renaissance School of Medicine at Stony Brook University, Stony Brook, New York.ORCID https://orcid.org/0000-0002-6124-0329
Josephine RiniDivision of Nuclear Medicine (C.C., J.R.), Department of Radiology, New York University School of Medicine, New York, New York.ORCID https://orcid.org/0009-0003-1173-8035
Ana M FranceschiFrom the Neuroradiology Division (F.M., M.C., A.M.F.), Department of Radiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, New York afranceschi@northwell.edu.ORCID https://orcid.org/0000-0003-2577-9738

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purpose[ MATERIALS AND

methodsFollowing institutional review board approval, a retrospective analysis was conducted of patients who underwent [

resultsTen female patients with ER-positive breast cancer with 90 metastatic brain and calvarial lesions were included in our analysis. The mean age was 64.3 (SD, 7.5) years. Twelve of 90 (13.3%) lesions were occult on contrast-enhanced brain MRI but detected by

conclusionsBy integrating [

Indexed as

Brain NeoplasmsEstradiolMagnetic Resonance ImagingPositron Emission Tomography Computed TomographyAdultAgedBreast NeoplasmsFemaleHumansMaleMiddle AgedMultimodal ImagingRadiopharmaceuticalsReceptors, EstrogenRetrospective Studies16-fluoroestradiolEstradiolRadiopharmaceuticalsReceptors, Estrogen

Identifiers

PMID40968016
PMCPMC12633678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.